Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-039712
Filing Date
2020-08-12
Accepted
2020-08-12 16:31:55
Documents
54
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vie-10q_20200630.htm 10-Q 2522190
2 EX-31.1 vie-ex311_6.htm EX-31.1 19149
3 EX-31.2 vie-ex312_9.htm EX-31.2 19321
4 EX-32.1 vie-ex321_8.htm EX-32.1 9408
5 EX-32.2 vie-ex322_7.htm EX-32.2 9835
  Complete submission text file 0001564590-20-039712.txt   6065297

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT vie-20200630.xml EX-101.INS 1003146
7 XBRL TAXONOMY EXTENSION SCHEMA vie-20200630.xsd EX-101.SCH 38397
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vie-20200630_cal.xml EX-101.CAL 45084
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vie-20200630_def.xml EX-101.DEF 97660
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE vie-20200630_lab.xml EX-101.LAB 304135
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vie-20200630_pre.xml EX-101.PRE 218137
Mailing Address 1 MEDIMMUNE WAY GAITHERSBURG MD 20878
Business Address 1 MEDIMMUNE WAY GAITHERSBURG MD 20878 240-558-0038
Viela Bio, Inc. (Filer) CIK: 0001734517 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39067 | Film No.: 201095839
SIC: 2834 Pharmaceutical Preparations